SCS gene therapy (Clearside Biomedical)

N/A

Report date: 2025/01/26 16:17:21

Base Information

Drug NameSCS gene therapy (Clearside Biomedical)
Drug Alias NameN/A
ClassificationBiologics
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsGenetic Diseases, InbornEye Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesClearside Biomedical Inc
China Registration ClassN/A

Develop Information

Active CompaniesClearside Biomedical Inc
Inactive CompaniesN/A
Active IndicationsGenetic Diseases, InbornEye Diseases
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A